Concepedia

Publication | Closed Access

Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies

164

Citations

21

References

2010

Year

References

YearCitations

Page 1